In nonhospitalized, unvaccinated adults with COVID-19, molnupiravir reduced hospitalization or death at 29 d.
Where this comes from
- Record sourced from PubMed, PMID 35377719.
- Also identified by DOI 10.7326/J22-0017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. <b>Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients.</b> N Engl J Med. 2022;386:509-20. 34914868.
Medical subject headings
- COVID-19